Project Grant HT94252411104
Award Date
9/30/24
Completion Date
9/29/28
Dollars Obligated
$724K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Jacksonville, FL 32224, USA
Similar Awards
The Department of the Army Medical Command awarded a $773,102 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to Mayo Clinic Jacksonville (A Nonprofit Corporation), doing business as Scott Lynch MD. The grant, titled "The Inclusive Cancer Care Research Equity (ICCARE) for Black Men Consortium", is for the period of September 30, 2024 to September 29, 2028. The grant supports advanced biomedical research initiatives focused on transforming...
This federal Project Grant award, titled "THE INCLUSIVE CANCER CARE RESEARCH EQUITY (ICCARE) FOR BLACK MEN CONSORTIUM", is funded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The $480,111 award to Mayo Clinic Jacksonville, a nonprofit healthcare organization, will support advanced biomedical research focused on transforming healthcare for military service members and the broader public. The research, with a...
The U.S. Department of the Army Medical Command awarded a $4,623,272 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to Mayo Clinic Jacksonville (A Nonprofit Corporation), doing business as Scott Lynch MD. The grant, titled "The Inclusive Cancer Care Research Equity (ICCARE) for Black Men Consortium," will support advanced biomedical research focused on transforming healthcare for military service members and the broader public. The four-year...
The Defense Health Agency awarded a $813,085 Project Grant to the Mayo Clinic Jacksonville (doing business as Scott Lynch MD), a non-profit healthcare and research institution, under the Military Medical Research and Development (CFDA 12.420) program. The grant, which runs from June 1, 2025 to May 31, 2028, supports advanced biomedical research to resolve the critical role of PINK1 expression and activity in Parkinson's disease pathophysiology and therapeutic intervention. As a prominent medical...
The Defense Health Agency awarded Mayo Clinic Jacksonville $3,232,027 under the Military Medical Research and Development federal grant program (CFDA 12.420) from September 15, 2023 through September 14, 2027. Through this award, Mayo Clinic will integrate molecular pathology, radiology, and genetics to improve breast cancer risk prediction. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform health care for service members...
The Defense Health Agency awarded a $1,162,900 Project Grant to the Mayo Clinic in Rochester, MN under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on July 15, 2025, is for the project "LAUNCHING THE ERA OF MELANOMA SURVIVORSHIP: DEFINING TREATMENT TARGETS IN QUALITY OF LIFE AND MENTAL HEALTH" and runs through July 14, 2028. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans,...
The Department of Defense's Defense Health Agency awarded a $621,435 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to Mayo Clinic Jacksonville, a nonprofit healthcare and research institution, for a project titled "Novel Alpha-Emitting Radiopharmaceutical Therapy for Radioiodine Refractory Differentiated Thyroid Cancer." The award period is from September 1, 2025 to August 31, 2027, and the project aims to develop and investigate innovative...
The U.S. Defense Health Agency awarded a $2,581,362 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to Mayo Clinic Jacksonville, a non-profit healthcare provider located in Jacksonville, Florida. The grant, titled "TARGETING PNLIP FOR SEVERE ACUTE PANCREATITIS THERAPY," will fund research aimed at developing new treatments for severe acute pancreatitis over a performance period from July 1, 2024 to June 30, 2027. As the prime awardee, Mayo Clinic...
The Defense Health Agency has awarded a $968,400 Project Grant to Mayo Clinic to develop a personalized approach to treating drug-resistant ovarian cancer. The grant, which began on June 1, 2024, and will run through May 31, 2028, is funded under the Military Medical Research and Development program (CFDA 12.420). This program supports biomedical research to improve the health and care of military service members, veterans, and their families. Through this award, Mayo Clinic will leverage its...
The Defense Health Agency awarded a $468,672 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to Georgia College & State University. The grant, titled "The Inclusive Cancer Care Research Equity (ICCARE) for Black Men Consortium," will fund research focused on examining health-seeking behaviors, decision-making, psychosocial effects, and coping mechanisms among Black men with prostate cancer. The project will also test the efficacy of...